Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of PRIC vs Pranlukast Dry Syrup in Healthy Volunteers
NCT03826485Phase 1Unknown
- Sponsor
- Sam-A Pharm
- Start
- Apr 2019
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pranlukast in asthma and allergic rhinitis (AR) (2 arms), sponsored by Sam-A Pharm. Primary endpoints: Area Under the Curve to last time point and Maximum concentration of drug. Status: unknown.
02
Drugs
pranlukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on NCT03826485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03826485.